Product
hAd5-S-Fusion+N-ETSD vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy VolunteersStatus: Completed, Estimated PCD: 2022-04-20